Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in Sweden and the UK: The Case of Risperidone Berdud M, Wallin-Bernhardsson N, Zamora B, Lindgren P & Towse, A Read more and download publication OHE Research Paper July 2019 Office of Health Economics, 2019